ECDC reports resistant Klebsiella pneumoniae bloodstream infections surged 72% in the EU, Iceland, Liechtenstein and Norway, where antibiotic-resistant infections kill over 35,000 people yearly.
More than 35,000 people die every year across the EU, Iceland, Liechtenstein and Norway from infections that antibiotics can no longer cure — a toll the ECDC compares to deaths from flu, tuberculosis and HIV combined.
This week, the European Centre for Disease Prevention and Control warned that the situation is worsening, not improving. Resistant bloodstream infections are climbing in several countries, and Europe is drifting further from its own reduction targets.
The stakes reach far beyond intensive care units. Without effective antibiotics, the agency’s latest report states, routine surgery, cancer chemotherapy and organ transplantation would become difficult or impossible to perform safely. “Without effective antibiotics, we could return to the ‘pre-antibiotic era’, and it would be difficult, if not impossible, to safely perform organ transplants, cancer chemotherapy, intensive care or other medical procedures,” the report warns, according to Euronews.com.
One Superbug Retreats While Another Surges
The sharpest contrast in the new data sits between two hospital bacteria. Bloodstream infections caused by methicillin-resistant Staphylococcus aureus (MRSA) fell 19% in 2025 compared with 2019, beating the EU’s target of a 15% reduction by 2030, according to Межа. Resistant Klebsiella pneumoniae bloodstream infections moved the opposite way: up 72% over the same period, against a target of a 5% reduction, as Межа reports.
Christian Giske told Politico — in reporting carried by Межа — that the drug-resistant Klebsiella findings were “the biggest concern” among the superbug data collected in Europe over the past year. Klebsiella infections carry a mortality rate generally between 40% and 70%, and the bacterium spreads from patient to patient inside hospitals, which makes it harder to contain than MRSA.
Some strains now resist nearly all antibiotics, including the newest ones.
E. coli tells a similar story. Resistant E. coli infections rose an estimated 16.4% between 2019 and 2025, Euronews.com reported, when the goal was a 10% reduction from the 2019 baseline, according to euronews.
Antibiotics Fail Against Viruses; Hospitals Drive Resistance
- Antibiotics do not work against viruses. Colds, and maux de gorge d’origine virale gain nothing from them, and every unnecessary course helps resistant bacteria survive and spread.
- Hospitals, not everyday life, drive most of the harm: more than 70% of Europe’s resistance burden comes from healthcare-associated infections with multidrug-resistant bacteria.
- Vaccination and hand hygiene reduce infections in the first place — which means fewer hospital admissions and fewer antibiotics overall.
Cyprus, Hungary and the Geography of the Surge
The burden is far from evenly spread. Cyprus recorded a 716% jump in antibiotic-resistant K. pneumoniae infections, reaching 21.29 cases per 100,000 people last year, alongside a 276% rise in resistant E. coli bloodstream infections, Euronews.com reports. Hungary’s resistant Klebsiella infections grew 1,622% in recent years; Croatia’s rose 409% and Bulgaria’s 356%.
| Country | Resistant K. pneumoniae per 100,000 (2025) | Reported increase |
|---|---|---|
| Cyprus | 21.29 | +716% |
| Romania | 18.66 | — |
| Greece | 16.28 | — |
| Hungary | — | +1,622% |
| Croatia | — | +409% |
| Bulgaria | — | +356% |
Giske said that to make face to the montée de la résistance, it must act on two fronts: preventing infections and mastering the use of antimicrobials. At the point of care, that means good hand hygiene and vaccination, he told Euronews.com. At the system level, it means genomic surveillance helps authorities evaluate more quickly the propagation of resistant bacteria.
Why the Wrong Drug at the Wrong Time Fuels the Crisis
The mechanism is selection pressure. Les nourrissons et les enfants d’âge préscolaire frequently receive unnecessary antibiotics for coughs, colds and sore throats that would resolve on their own, the agency specified.
France illustrates the pattern. Santé publique France’s annual study, published this Tuesday, November 17, for World Antimicrobial Resistance Awareness Week and reported by Paris Match, found a notable drop in antibiotic consumption in 2025 after a rebound in 2024 to pre-Covid levels.
Yet France still recorded 741 prescriptions per 1,000 inhabitants — well above the 650 prescriptions per an d’ici 2027 target set by the Stratégie nationale de prévention des infections et de l’antibiorésistance — and ranks fourth-highest for antibiotic consumption in Europe.
Paris Match also reports a French warning light: resistance to carbapenems — last-resort antibiotics for severe infections caused by multidrug-resistant bacteria — more than tripled in French hospitals since 2019. Resistance to fluoroquinolones, used for urinary infections, meanwhile improved, falling 9% in community care and 11.6% in nursing homes.
What Happens Next in Brussels and Beyond
The EU’s new pharmaceutical legislation is due to be promulgated in December, Межа reports, arriving as the bloc remains far from several 2030 reduction targets and the number of new drugs available to treat them is limited. Genomic surveillance, the ECDC notes, is helping authorities track resistant strains faster, guide treatment decisions and identify where new drugs are most urgently needed.
The evidence comes from public agencies: the ECDC is an EU agency, and Santé publique France is France’s national public health agency — both bodies whose data underpin this reporting.
Avoid Antibiotics for Viral Illness; Seek Care for Worsening Symptoms
Do not press a clinician for antibiotics for colds, flu or COVID-19; the ECDC states these bring no therapeutic benefit. Follow the prescription exactly as written when one is given, and never reuse leftover antibiotics from a previous illness.
Seek medical care promptly for high fever, confusion, or symptoms that worsen despite treatment — resistant bloodstream infections, which the ECDC flags as a particular concern, carry high mortality and need rapid clinical evaluation. Vaccination and hand hygiene, per the agency's guidance, remain the strongest preventive steps available to individuals.
The trajectory, on the current numbers, is uneven: one hospital superbug is bending downward, another is climbing steeply, and the gap between them is widening. “La résistance […] va plus vite que les progrès de la médecine moderne et menace la santé des familles dans le monde entier,” WHO Director-General Tedros Adhanom Ghebreyesus warned last year, as quoted by Paris Match.
References
- European Centre for Disease Prevention and Control (ECDC), antimicrobial resistance and healthcare-associated infections report, 2026
- Santé publique France, annual antibiotic consumption and resistance study, published November 2026 for World AMR Awareness Week
- World Health Organization, statements by Director-General Tedros Adhanom Ghebreyesus on antimicrobial resistance